Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP802421.RAWE-A3ATGYJ2KVFVMDezXWtCVMYL7plRnb1dmB7brQqM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP802421.RAWE-A3ATGYJ2KVFVMDezXWtCVMYL7plRnb1dmB7brQqM130_assertion type Assertion NP802421.RAWE-A3ATGYJ2KVFVMDezXWtCVMYL7plRnb1dmB7brQqM130_head.
- NP802421.RAWE-A3ATGYJ2KVFVMDezXWtCVMYL7plRnb1dmB7brQqM130_assertion description "[These data suggest that the tumor-associated antigen MRP3 has potential use for prognosis and as a target for malignant glioma immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802421.RAWE-A3ATGYJ2KVFVMDezXWtCVMYL7plRnb1dmB7brQqM130_provenance.
- NP802421.RAWE-A3ATGYJ2KVFVMDezXWtCVMYL7plRnb1dmB7brQqM130_assertion evidence source_evidence_literature NP802421.RAWE-A3ATGYJ2KVFVMDezXWtCVMYL7plRnb1dmB7brQqM130_provenance.
- NP802421.RAWE-A3ATGYJ2KVFVMDezXWtCVMYL7plRnb1dmB7brQqM130_assertion SIO_000772 20809959 NP802421.RAWE-A3ATGYJ2KVFVMDezXWtCVMYL7plRnb1dmB7brQqM130_provenance.
- NP802421.RAWE-A3ATGYJ2KVFVMDezXWtCVMYL7plRnb1dmB7brQqM130_assertion wasDerivedFrom befree-20150227 NP802421.RAWE-A3ATGYJ2KVFVMDezXWtCVMYL7plRnb1dmB7brQqM130_provenance.
- NP802421.RAWE-A3ATGYJ2KVFVMDezXWtCVMYL7plRnb1dmB7brQqM130_assertion wasGeneratedBy ECO_0000203 NP802421.RAWE-A3ATGYJ2KVFVMDezXWtCVMYL7plRnb1dmB7brQqM130_provenance.